In our cannabinoid series that examines current dermatologic pros and cons, Dr. Shawn Kwatra is cautiously optimistic, but advises to proceed with caution.

In our cannabinoid series that examines current dermatologic pros and cons, Dr. Adam Friedman talks CBD vs medical cannabis, dispensaries, and navigating state regulations.

In our cannabinoid series that examines current dermatologic pros and cons, Dr. Adam Friedman discusses the potential for CBD in dermatology, the science, and current clinical trial programs.

The recent winter storm in Texas has Ted Rosen, MD, talking adversity, resilience and hope in medicine and in life.

Dr. Mayar Mohajer discusses data he presented at IDWeek 2020 that examines what happens to COVID rates of infection when healthcare workers wear face shields and masks together.

Ted Talks, but sometimes Ted Rants. This time? He's perturbed about the sometimes-sinister side of posters.

Todd Schlesinger, MD, discusses advanced treatment for advanced skin cancers from the 2020 Fall Clinical Dermatology Conference.

Ted Rosen, MD, discusses his recent review article about STDs in the era of COVID.

Heather Woolery-Lloyd, MD, a board-certified dermatologist and a member of the American College of Lifestyle Medicine, discusses the six lifestyle interventions to treat age-related and chronic dermatologic diseases—and provides their evidence bases.

Dr. Keri highlights recent research that links the role of diet to many common dermatological conditions—especially those with an inflammatory component.